ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Cansino Biologics Inc (PK)

Cansino Biologics Inc (PK) (CASBF)

2.60
0.00
(0.00%)
終了 7月13日 5:00AM

Cansino Biologics Inc (PK) (CASBF) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

主要統計と詳細

通貨
2.60
( - )
買値
2.53
売値
3.42
出来高
-
平均取引量 (3 か月)
US$ 1,031,481
財務取引量
-
0.00 日の範囲 0.00
2.60 52 週間の範囲 6.99
時価総額
企業価値
7.191B
前日終値
2.60
始値
-
時刻
最終取引時間
VWAP
-
歳入
1.12B
純利益
-1.01M
発行済株式数
247,043,801
浮動株比率 (%)
64.72%
機関投資家保有比率 (%)
8.13%
配当利回り
PER
-5.15k
株価売上高倍率 (PSR)
7.53
1 株当たり利益 (EPS)
-0
ベータ
1.2

Cansino Biologics Inc (PK) について

CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People’s Republic of China. The company develops Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningit... CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People’s Republic of China. The company develops Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides. It develops DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary vaccination. In addition, it develops Tdcp Adolescent and Adult vaccine for treating pertussis; PBPV, a serotype-independent protein-based pneumococcal vaccine that is in Phase I clinical trial; PCV13i, a pneumococcal conjugate vaccine, which is in Phase I clinical trial; and TB Booster for the BCG-vaccinated population which is in Phase I clinical trial. Further, it is developing various preclinical stage products, including DTcP-Hib Combo vaccine; and CS-2023 to treat meningitis. The company was incorporated in 2009 and is headquartered in Tianjin, the People’s Republic of China. 詳細を表示

セクター
-
業界
-
ウェブサイト
本社
Tianjin, China
設立
2026
Cansino Biologics Inc (PK) is listed in the sector of the その他OTC with ticker CASBF. The last closing price for Cansino Biologics (PK) was US$2.60. Over the last year, Cansino Biologics (PK) shares have traded in a share price range of US$ 2.60 to US$ 6.99.

Cansino Biologics (PK) currently has 247,043,801 shares in issue. The market capitalisation of Cansino Biologics (PK) is US$642.31 million. Cansino Biologics (PK) has a price to earnings ratio (PE ratio) of -5,153.58.

CASBF 最新ニュース

表示するニュースはありません。
期間 †前日比前日比 %始値高値安値平均出来高VWAP
1002.62.62.62002.6CS
4-0.26-9.090909090912.862.862.61332.665CS
12-1.26-32.64248704663.8642.64363.48577982CS
26-2.145-45.20547945214.7454.7452.63713.66320498CS
52-2.4-4856.992.614944.38147055CS
156-0.9-25.71428571433.56.991.8618483.38157845CS
260-38.19-93.625888698240.7949.021.86231915.31132774CS

CASBF - Frequently Asked Questions (FAQ)

What is the current Cansino Biologics Inc (PK) share price?
The current share price of Cansino Biologics Inc (PK) is US$ 2.60
How many Cansino Biologics Inc (PK) shares are in issue?
Cansino Biologics Inc (PK) has 247,043,801 shares in issue
What is the market cap of Cansino Biologics Inc (PK)?
The market capitalisation of Cansino Biologics Inc (PK) is USD 642.31M
What is the 1 year trading range for Cansino Biologics Inc (PK) share price?
Cansino Biologics Inc (PK) has traded in the range of US$ 2.60 to US$ 6.99 during the past year
What is the PE ratio of Cansino Biologics Inc (PK)?
The price to earnings ratio of Cansino Biologics Inc (PK) is -5.15k
What is the cash to sales ratio of Cansino Biologics Inc (PK)?
The cash to sales ratio of Cansino Biologics Inc (PK) is 7.53
What is the registered address of Cansino Biologics Inc (PK)?
The registered address for Cansino Biologics Inc (PK) is 401-420, Biomedical Park, Tianjin, 300457
What is the Cansino Biologics Inc (PK) website address?
The website address for Cansino Biologics Inc (PK) is cansinotech.com

CASBF 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

CASBF Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock